Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Dual resistance to cold and ethanol in Penicillium species persistently contaminating donated cadavers

Created on 12 Nov 2025

Authors

Yoshinouchi, T., Nakamura, T., Manabe, M., Mori, D., Yasunaga, J.-i., Tanaka, Y., Iwanaga, J., Kitagawa, N.

Abstract

Modern cadaver preservation techniques, such as low-concentration formaldehyde methods, are increasingly adopted to mitigate health risks and improve tissue fidelity for medical education and surgical training. However, these environments potentially foster fungal contamination. This study aimed to identify contaminating species from cadaveric surfaces stored under specific preservation conditions and establish effective countermeasures. Genetic identification revealed Penicillium paneum as the predominant species, while Penicillium corylophilum was also detected. These species exhibited distinctive traits, including vigorous growth at 4{degrees}C and marked ethanol tolerance, that explain their persistence in this preservation environment. Antifungal susceptibility testing demonstrated that these isolates were highly susceptible to commonly used disinfectants such as benzalkonium chloride, chlorhexidine gluconate, and phenol. Our findings indicate that these Penicillium species are uniquely adapted to low-temperature and ethanol-rich preservation environments. The incorporation of the identified disinfectants into preservation solutions offers a practical and effective strategy for controlling persistent fungal contamination in cadaveric facilities.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 12 Nov 2025.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 30
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement